UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Consumer-oriented CSR communication: focusing on ability or morality?

Corporate communications, 2012-01, Vol.17 (1), p.29-49

Schmeltz, Line

2012

Volltextzugriff (PDF)

Reversal of Latency as Part of a Cure for HIV-1

Trends in microbiology (Regular ed.), 2016-02, Vol.24 (2), p.90-97

2016

Volltextzugriff (PDF)

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: author's response

Clinical microbiology and infection, 2022-11, Vol.28 (11), p.1518-1518

Søgaard, Ole Schmeltz

2022

Volltextzugriff (PDF)

Risk characterization of hospitalizations for mental illness and/or behavioral disorders with concurrent heat-related illness

PloS one, 2017-10, Vol.12 (10), p.e0186509-e0186509

2017

Volltextzugriff (PDF)

Climate Change Is Already Exacerbating Current Social Inequities

American journal of public health (1971), 2021-01, Vol.111 (1), p.10-11

Schmeltz, Michael T

2021

Volltextzugriff (PDF)

A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells

Journal of virology, 2016-05, Vol.90 (9), p.4441-4453

2016

Volltextzugriff (PDF)

TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure

Frontiers in immunology, 2021-09, Vol.12, p.704617-704617

2021

Volltextzugriff (PDF)

First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

BMC infectious diseases, 2021-01, Vol.21 (1), p.39-39, Article 39

2021

Volltextzugriff (PDF)

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies

Frontiers in immunology, 2020-06, Vol.11, p.1112-1112

2020

Volltextzugriff (PDF)

Getting CSR communication fit: A study of strategically fitting cause, consumers and company in corporate CSR communication

Public relations inquiry, 2017-01, Vol.6 (1), p.47-72

Schmeltz, Line

2017

Volltextzugriff (PDF)

Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections

Nature communications, 2022-08, Vol.13 (1), p.4466-4466, Article 4466

2022

Volltextzugriff (PDF)

906-P: Safety and Efficacy of Continuous Glucose Monitoring at an ADA Camp

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Extreme Heat Governance: A Critical Analysis of Heat Action Plans in California

American journal of public health (1971), 2023-01, Vol.113 (1), p.15-19

2023

Volltextzugriff (PDF)

Strategies for enhancing CAR T cell expansion and persistence in HIV infection

Frontiers in immunology, 2023-08, Vol.14, p.1253395-1253395

2023

Volltextzugriff (PDF)

Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

BMC immunology, 2023-11, Vol.24 (1), p.45-45, Article 45

2023

Volltextzugriff (PDF)

Identical or Just Compatible? The Utility of Corporate Identity Values in Communicating Corporate Social Responsibility

International journal of business communication (Thousand Oaks, Calif.), 2014-07, Vol.51 (3), p.234-258

Schmeltz, Line

2014

Volltextzugriff (PDF)

The Atmospheric Mercury Network: measurement and initial examination of an ongoing atmospheric mercury record across North America

Atmospheric chemistry and physics, 2013-11, Vol.13 (22), p.11339-11349

2013

Volltextzugriff (PDF)

Risk and outcome of pyelonephritis among renal transplant recipients

BMC infectious diseases, 2016-06, Vol.16 (1), p.264-264, Article 264

2016

Volltextzugriff (PDF)

Broadly neutralizing antibodies for HIV treatment and cure approaches

Current opinion in HIV & AIDS, 2023-07, Vol.18 (4), p.157-163

2023

Volltextzugriff (PDF)

The challenges of balancing ethics and competence for purpose-driven brands: an exploratory case study on social impact company Too Good To Go

The journal of brand management, 2024-05, Vol.31 (3), p.310-330

2024

Volltextzugriff (PDF)

Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization

Clinical microbiology and infection, 2022-10, Vol.28 (10), p.1316-1318

2022

Volltextzugriff (PDF)

Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation

Human vaccines & immunotherapeutics, 2013-05, Vol.9 (5), p.993-1001

2013

Volltextzugriff (PDF)

Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission

Current opinion in HIV & AIDS, 2020-09, Vol.15 (5), p.309-315

2020

Volltextzugriff (PDF)

Broad activation of latent HIV-1 in vivo

Nature communications, 2016-09, Vol.7 (1), p.12731-12731, Article 12731

2016

Volltextzugriff (PDF)

Economic Burden of Hospitalizations for Heat-Related Illnesses in the United States, 2001-2010

International journal of environmental research and public health, 2016-09, Vol.13 (9), p.894

2016

Volltextzugriff (PDF)

1 – 25 von 367

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(285)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(312)
Französisch
(27)
Deutsch
(26)
Dänisch
(1)
Latein
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(114)
Humans
(94)
Physical Sciences
(49)
Female
(48)
Male
(48)
Middle Aged
(36)
Aged
(31)
Adult
(30)
Infectious Diseases
(30)
Immunology
(26)
Chemistry
(23)
Hiv
(19)
Mortality
(19)
Science & Technology - Other Topics
(19)
Environmental Sciences & Ecology
(18)
Life Sciences
(17)
Multidisciplinary Sciences
(17)
Risk Factors
(17)
Adolescent
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Consumer-oriented CSR communication: focusing on ability or morality?

Reversal of Latency as Part of a Cure for HIV-1

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: author's response

Risk characterization of hospitalizations for mental illness and/or behavioral disorders with concurrent heat-related illness

Climate Change Is Already Exacerbating Current Social Inequities

A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells

TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure

First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies

Getting CSR communication fit: A study of strategically fitting cause, consumers and company in corporate CSR communication

Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections

906-P: Safety and Efficacy of Continuous Glucose Monitoring at an ADA Camp

Extreme Heat Governance: A Critical Analysis of Heat Action Plans in California

Strategies for enhancing CAR T cell expansion and persistence in HIV infection

Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Identical or Just Compatible? The Utility of Corporate Identity Values in Communicating Corporate Social Responsibility

The Atmospheric Mercury Network: measurement and initial examination of an ongoing atmospheric mercury record across North America

Risk and outcome of pyelonephritis among renal transplant recipients

Broadly neutralizing antibodies for HIV treatment and cure approaches

The challenges of balancing ethics and competence for purpose-driven brands: an exploratory case study on social impact company Too Good To Go

Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization

Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation

Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission

Broad activation of latent HIV-1 in vivo

Economic Burden of Hospitalizations for Heat-Related Illnesses in the United States, 2001-2010

Suchergebnisse filtern